Skip to main content
. 2020 Jul 7;2020(7):CD008946. doi: 10.1002/14651858.CD008946.pub3

Summary of findings 1. IFN‐α + PUVA compared to PUVA alone for mycosis fungoides.

IFN‐α + PUVA compared to PUVA alone for mycosis fungoides
Patient or population: people with mycosis fungoides
Setting: tertiary care setting
Intervention: IFN‐α + PUVA
Comparison: PUVA alone
Number of trials included: 2 (Stadler 2006; Wozniak 2008)
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Risk with PUVA alone Risk with IFN‐α + PUVA
Improvement of quality of life Not measured
Common adverse effects Not measured
Complete response (CR)
assessed with: outcome assessment not described
Time point of measurement
Stadler 2006: up to week 52
Wozniak 2008: up to week 24
Study population RR 1.07
(0.87 to 1.31) 122
(2 RCTs) ⊕⊕⊝⊝
Low a
731 per 1000 783 per 1000
(636 to 958)
Objective response rate (ORR) Not measured
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). The assumed risk is based on the number of events/number of participants in the control groups in Analysis 5.1.
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

a Downgraded by two levels to low‐certainty evidence. One level because of low internal validity (risk of bias ‐ performance bias in both studies, attrition bias in Stadler 2006) and one level because of low sample size (imprecision)